Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance.

Abdel-Maksoud M, House B, Wasfy M, Abdel-Rahman B, Pimentel G, Roushdy G, Dueger E.

Ann Clin Microbiol Antimicrob. 2012 Aug 28;11:24. doi: 10.1186/1476-0711-11-24.

2.

Seroepidemiological and microbiological study of brucellosis in Kuwait.

Dimitrov Ts, Panigrahi D, Emara M, Awni F, Passadilla R.

Med Princ Pract. 2004 Jul-Aug;13(4):215-9.

3.

In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.

Turkmani A, Ioannidis A, Christidou A, Psaroulaki A, Loukaides F, Tselentis Y.

Ann Clin Microbiol Antimicrob. 2006 Oct 2;5:24.

4.

In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.

Deshmukh A, Hagen F, Sharabasi OA, Abraham M, Wilson G, Doiphode S, Maslamani MA, Meis JF.

BMC Microbiol. 2015 Jun 16;15:121. doi: 10.1186/s12866-015-0458-9.

5.

[E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].

Sengöz G, Yaşar KK, Kutlu SB, Durdu YB, Ozdemir R, Nazlican O.

Mikrobiyol Bul. 2006 Jul;40(3):265-8. Turkish.

PMID:
17001857
6.

Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.

Tanyel E, Coban AY, Koruk ST, Simsek H, Hepsert S, Cirit OS, Tulek N.

Saudi Med J. 2007 Aug;28(8):1239-42.

PMID:
17676210
7.

Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.

Bayram Y, Korkoca H, Aypak C, Parlak M, Cikman A, Kilic S, Berktas M.

Int J Med Sci. 2011 Mar 3;8(3):198-202.

8.
9.

Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.

Razzaghi R, Rastegar R, Momen-Heravi M, Erami M, Nazeri M.

Indian J Med Microbiol. 2016 Jul-Sep;34(3):342-5. doi: 10.4103/0255-0857.188336.

10.

Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.

Parlak M, Güdücüoğlu H, Bayram Y, Çıkman A, Aypak C, Kılıç S, Berktaş M.

Int J Med Sci. 2013 Aug 22;10(10):1406-11. doi: 10.7150/ijms.6565. eCollection 2013.

11.

In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.

Bosch J, Liñares J, López de Goicoechea MJ, Ariza J, Cisnal MC, Martin R.

J Antimicrob Chemother. 1986 Apr;17(4):459-61.

PMID:
2940209
12.

Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp.

Ozhak-Baysan B, Ongut G, Ogunc D, Gunseren F, Sepin-Ozen N, Ozturk F, Aktepe OC, Gultekin M.

Pol J Microbiol. 2010;59(1):55-60.

13.

Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.

Marianelli C, Graziani C, Santangelo C, Xibilia MT, Imbriani A, Amato R, Neri D, Cuccia M, Rinnone S, Di Marco V, Ciuchini F.

J Clin Microbiol. 2007 Sep;45(9):2923-8. Epub 2007 Jul 18.

14.

Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.

López-Merino A, Contreras-Rodríguez A, Migranas-Ortiz R, Orrantia-Gradín R, Hernández-Oliva GM, Gutiérrez-Rubio AT, Cardeñosa O.

Scand J Infect Dis. 2004;36(9):636-8.

PMID:
15370648
15.

Biotypes and antimicrobial susceptibilities of Brucella isolates.

Bodur H, Balaban N, Aksaray S, Yetener V, Akinci E, Colpan A, Erbay A.

Scand J Infect Dis. 2003;35(5):337-8.

PMID:
12875523
16.

Identification of Brucella species isolated from proven brucellosis patients in Izmir, Turkey.

Köse S, Kiliç S, Ozbel Y.

J Basic Microbiol. 2005;45(4):323-7.

PMID:
16028204
17.

Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

Ariza J, Bosch J, Gudiol F, Liñares J, Viladrich PF, Martín R.

Antimicrob Agents Chemother. 1986 Dec;30(6):958-60.

18.

In vitro antimicrobial susceptibility of Brucella species.

Baykam N, Esener H, Ergönül O, Eren S, Celikbas AK, Dokuzoguz B.

Int J Antimicrob Agents. 2004 Apr;23(4):405-7.

PMID:
15081093
19.

[Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].

Alişkan H, Turunç T, Demiroğlu YZ, Colakoğlu S, Arslan H.

Mikrobiyol Bul. 2008 Jan;42(1):125-9. Turkish.

PMID:
18444570
20.

In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.

Turan H, Arslan H, Azap OK, Serefhanoğlu K, Uncu H.

Int J Antimicrob Agents. 2007 Aug;30(2):186-7. Epub 2007 Apr 25. No abstract available.

PMID:
17462865

Supplemental Content

Support Center